Artificial intelligence to assist the echocardiographic identification of transthyretin cardiac amyloidosis
Sign Up to like & getrecommendations! Published in 2024 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehae666.1810
Abstract: Transthyretin cardiac amyloidosis (ATTR-CM) is a severe disease, and treatments are most effective when initiated at early stage. Echocardiography is the main tool for screening patients with suspected ATTR-CM or populations at high risk of… read more here.
Keywords: artificial intelligence; attr; transthyretin cardiac; intelligence assist ... See more keywords